3E-methylglutaconic acid

3e-methylglutaconic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 473 references associated with 3E-methylglutaconic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 3E-methylglutaconic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 3E-methylglutaconic acid

MeSH term MeSH ID Detail
Acidosis, Lactic D000140 8 associated lipids
Liver Diseases D008107 31 associated lipids
Quadriplegia D011782 4 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Acidosis, Renal Tubular D000141 4 associated lipids
Brain Diseases, Metabolic, Inborn D020739 10 associated lipids
Cardiomyopathies D009202 10 associated lipids
Neutropenia D009503 15 associated lipids
Per page 10 20 50 | Total 23

PubChem Associated disorders and diseases

All references with 3E-methylglutaconic acid

Download all related citations
Per page 10 20 50 100 | Total 121
Authors Title Published Journal PubMed Link
Ly TB et al. Mutations in the AUH gene cause 3-methylglutaconic aciduria type I. 2003 Hum. Mutat. pmid:12655555
Laube GF et al. Nephrocalcinosis and medullary cysts in 3-methylglutaconic aciduria. 2003 Pediatr. Nephrol. pmid:12750979
Schlame M et al. Phospholipid abnormalities in children with Barth syndrome. 2003 J. Am. Coll. Cardiol. pmid:14662265
Rugolotto S et al. Long-term treatment of Barth syndrome with pantothenic acid: a retrospective study. 2003 Mol. Genet. Metab. pmid:14654353
Kleta R et al. 3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings. 2002 Mol. Genet. Metab. pmid:12126933
Sakamoto O et al. Novel missense mutation (R94S) in the TAZ ( G4.5) gene in a Japanese patient with Barth syndrome. 2002 J. Hum. Genet. pmid:12032589
Scaglia F et al. Neonatal presentation of ventricular tachycardia and a Reye-like syndrome episode associated with disturbed mitochondrial energy metabolism. 2002 BMC Pediatr pmid:12507404
Anikster Y et al. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. 2001 Am. J. Hum. Genet. pmid:11668429
Mazzocco MM and Kelley RI Preliminary evidence for a cognitive phenotype in Barth syndrome. 2001 Am. J. Med. Genet. pmid:11503166
Scaglia F et al. Mitochondrial DNA depletion associated with partial complex II and IV deficiencies and 3-methylglutaconic aciduria. 2001 J. Child Neurol. pmid:11292221

Table of Content